Activated platelets stimulate effector CD8+ T cells to enhance HNSCC immunotherapy efficacy

Abstract Programmed Death Receptor-1 (PD-1) is an immune checkpoint receptor expressed on the surface of T cells. Monoclonal antibodies targeting PD-1 and its ligand, PD-L1, are among the most widely utilized immune checkpoint inhibitors in cancer immunotherapy, dramatically improving the prognosis...

Descrición completa

Detalles Bibliográficos

Principais autores:	Zhennan Yuan, Lunhua Guo, Yuheng Pang, Wenjing Wang, Yuefeng Shang, Chufei Xie, Cheng Qian, Ji Sun, Xiaohong Wu
Formato:	Artigo
Idioma:	Inglês
Publicado:	Springer 2025-05-01
Series:	Discover Oncology
Assuntos:	HNSCC PD-1 CyTOF Platelet
Acceso en liña:	https://doi.org/10.1007/s12672-025-02596-y
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!